Economic and social footprint of the pharmaceutical industry in Europe
From employment to investment, research to new treatments, as an industry, we won’t rest in creating a healthier future for Europe.
Economic and social footprint of the pharmaceutical industry in Europe
PwC’s analysis estimates that, in 2016, 2.5 million jobs were supported by the pharmaceutical sector, with the average Gross Value Added per employee significantly higher than that of other key sectors at €156,000. The activities of the pharmaceutical industry directly contributed nearly €100 billion to EU economies in 2016, with an additional €106 billion provided through the supply chain and employee spending. Importantly, the report also provides an analysis of the impact of new medicines on patients’ lives, looking at indicators such as gains in healthy life years and ability to work, across selected disease areas.
For further reading:
EFPIA Economic & Societal Footprint Industry Report
EFPIA Economic & Societal Footprint Industry Technical Report
For further reading:
EFPIA Economic & Societal Footprint Industry Report
EFPIA Economic & Societal Footprint Industry Technical Report